GB1287317A - Novel adamantylurea derivatives and a process for the preparation thereof - Google Patents
Novel adamantylurea derivatives and a process for the preparation thereofInfo
- Publication number
- GB1287317A GB1287317A GB5049070A GB5049070A GB1287317A GB 1287317 A GB1287317 A GB 1287317A GB 5049070 A GB5049070 A GB 5049070A GB 5049070 A GB5049070 A GB 5049070A GB 1287317 A GB1287317 A GB 1287317A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- formula
- adamantyl
- alkyl
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Abstract
1287317 Adamantylurea derivatives CILAG CHEMIE AG 23 Out 1970 [28 Oct 1969 2 Sept 1970] 50490170 Heading C2C The invention comprises adamantylurea derivatives of the Formula Ib wherein R 1 and R 2 each are H or C 1-12 alkyl; Alk is C 1-10 alkylene; R 3 is H, C 1-12 alkyl, di- (C 1-5 alkyl) amino-C 1-5 alkyl, benzyl, 4-(N- methyl)piperidyl, or a group of the formula R<SP>1</SP>-(O-R<SP>11</SP>) n -R<SP>111</SP>-, in which R<SP>1</SP> is CH 3 or CH 2 CH 3 , R<SP>11</SP> and R<SP>111</SP> each are -CH 2 - or -CH 2 -CH 2 -, and n is 0 to 3; provided that when one of R 1 or R 2 is an alkyl group of more than 5 carbon atoms, then the other group is H or C 1-5 alkyl, Alk is CH 2 and R 3 is C 1-5 alkyl, the therapeutically active acid addition salts of the foregoing compounds which contain a basic nitrogen, and N - (1 - adamantyl) - N<SP>1</SP> - (ethoxycarbonyl)-urea. The latter compound is prepared by reacting ethoxycarbonyl isocyanate with 1-amino adamantane in an anhydrous organic solvent. Compounds of Formula Ib above may be obtained by one of the following methods: (a) reacting 1-adamantane isocyanate with compounds of the formula (b) reacting the appropriate aminoadamantanes with compounds of the formula (R 3 is not equal to H) in anhydrous organic solvents; (c) reacting the appropriate compound of the formula AdN(R 1 )COCl (Ad is 1-adamantyl) with compounds of the formula HNR 2 -Alk COOR 3 (R 3 is not H) in anhydrous organic solvents; (d) reacting the appropriate aminadamantanes with compounds of the formula ClOC-NR 2 -Alk COOR 3 (R 3 is not H) in anhydrous organic solvents, and, if desired, esterifying the compounds thus obtained in which R 3 is H, or hydrolysing the compounds thus obtained wherein R 3 is other than H. The following intermediates and starting materials are prepared: N - (1 - Adamantyl) - N - ethylcarbamoyl chloride, N - (1 - adamantyl) - N - methylcarbamoyl chloride, N - (ethoxycarbonylmethyl)-N- methylcarbamoyl chloride, N - (1 - adamantyl)-N- propyicarhamoyl chloride, N - (1 - adamantyl)- N - octylcarbamoyl chloride, N - (1 - adamantyl) - N<SP>1</SP> - (chlorocarbonylmethyl) urea, N - ( 1 - adaman - tyl) - N - (α - chlorocarbonylethyl) urea, 1-octanoylaminoadamantane, 1 - (octylamino) adamantane, pentylaminoacetonitrile, pentylaminoacetic acid hydrochloride, ethyl pentylaminoacetate, ethyl octylaminoacetate, 1 - (sec.- butylamino) adamantane, 3,6 - diazaheptyl isocyantoacetate, 3,6,9,12- tetraoxa - trideconyl isocyanatoacetate and 2-dimethylaminoethyl isocyantoacetate hydrochloride. Pharmaceutical compositions have anti-viral activity, contain the above novel adamantane derivatives and pharmaceutically acceptable carriers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87408469A | 1969-10-28 | 1969-10-28 | |
US6915070A | 1970-09-02 | 1970-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1287317A true GB1287317A (en) | 1972-08-31 |
Family
ID=26749738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5049070A Expired GB1287317A (en) | 1969-10-28 | 1970-10-23 | Novel adamantylurea derivatives and a process for the preparation thereof |
Country Status (9)
Country | Link |
---|---|
AT (1) | AT302348B (en) |
BE (1) | BE758165A (en) |
CH (1) | CH543487A (en) |
DE (1) | DE2052256A1 (en) |
ES (1) | ES384946A1 (en) |
FR (1) | FR2070171B1 (en) |
GB (1) | GB1287317A (en) |
NL (1) | NL7015825A (en) |
SE (1) | SE356044B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090326039A1 (en) * | 2003-04-03 | 2009-12-31 | The Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
WO2010112946A1 (en) | 2009-03-31 | 2010-10-07 | Rudjer Boskovic Institute | Adamantane bisurea derivatives, method of preparation and application in anion sensing |
US8513302B2 (en) | 2003-04-03 | 2013-08-20 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002507591A (en) * | 1998-03-26 | 2002-03-12 | ユニバーシティ オブ サスカチワン テクノロジーズ インコーポレイテッド | Aliphatic aminocarboxylic acids and aminophosphonic acids, aminonitrile and aminotetrazole as cell rescue agents |
US6984754B1 (en) | 1998-03-26 | 2006-01-10 | University Of Saskatchewan Technologies Inc. | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH456570A (en) * | 1965-11-18 | 1968-07-31 | Geigy Ag J R | Process for the production of new substituted urea derivatives |
-
0
- BE BE758165D patent/BE758165A/en unknown
-
1970
- 1970-10-20 CH CH1551570A patent/CH543487A/en not_active IP Right Cessation
- 1970-10-21 SE SE1417970A patent/SE356044B/xx unknown
- 1970-10-23 GB GB5049070A patent/GB1287317A/en not_active Expired
- 1970-10-24 DE DE19702052256 patent/DE2052256A1/en active Pending
- 1970-10-27 FR FR7038744A patent/FR2070171B1/fr not_active Expired
- 1970-10-27 ES ES384946A patent/ES384946A1/en not_active Expired
- 1970-10-28 NL NL7015825A patent/NL7015825A/xx unknown
- 1970-10-28 AT AT969670A patent/AT302348B/en not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090326039A1 (en) * | 2003-04-03 | 2009-12-31 | The Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
US8455652B2 (en) * | 2003-04-03 | 2013-06-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Inhibitors for the soluble epoxide hydrolase |
US8513302B2 (en) | 2003-04-03 | 2013-08-20 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
WO2010112946A1 (en) | 2009-03-31 | 2010-10-07 | Rudjer Boskovic Institute | Adamantane bisurea derivatives, method of preparation and application in anion sensing |
Also Published As
Publication number | Publication date |
---|---|
DE2052256A1 (en) | 1971-05-06 |
AT302348B (en) | 1972-10-10 |
ES384946A1 (en) | 1973-09-01 |
NL7015825A (en) | 1971-05-03 |
FR2070171A1 (en) | 1971-09-10 |
CH543487A (en) | 1973-10-31 |
BE758165A (en) | 1971-04-28 |
SE356044B (en) | 1973-05-14 |
FR2070171B1 (en) | 1975-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL174116B1 (en) | 7-(substituted)-9-[(substituted glycil) amido]-6-demethyl-6-deoxy-tetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts and metal complex, pharmaceutical agent and veterinary agent | |
GB1466646A (en) | Substituted benzamides | |
IE35909B1 (en) | Acylxylidide local anaesthetics | |
GB1287317A (en) | Novel adamantylurea derivatives and a process for the preparation thereof | |
GB1212460A (en) | Naphthacene derivatives | |
GB1110099A (en) | Urea and thiourea derivatives | |
GB1383888A (en) | Amino ether derivatives of orthothymatic esters | |
GB1041783A (en) | New benzenesulphonyl-cyclohexyl ureas, preparations containing them and process for their manufacture | |
GB1374365A (en) | Nitrosourea derivatives | |
GB1318479A (en) | N-bicycloamino-alkanoyl-anilines | |
GB1466822A (en) | Substituted benzamides | |
IE31997L (en) | Arylalkyloxy-benzamides | |
GB815885A (en) | Sulphonyl-ureas and a process for their manufacture | |
IE32154L (en) | Benzamide derivatives | |
US3646109A (en) | Benzylamine substituted carbamates | |
GB1305725A (en) | ||
GB1262052A (en) | Dibenzofuran derivatives | |
GB1024495A (en) | N-substituted n-arylsulphonyl ureas and processes for their production | |
ES368607A1 (en) | 1-substituted-2 5-diphenylpyrroles | |
US3544579A (en) | Substituted phenylcarbamic acid esters of cyclic amino alcohols | |
GB852422A (en) | New urea derivatives and process for their manufacture | |
GB1193534A (en) | Novel Benzazocine Derivatives, the Preparation thereof and Compositions Containing the same | |
GB1422221A (en) | Preparation of 2-alkoxybenzamides | |
GB950140A (en) | New azo dyes | |
GB1037655A (en) | Di(aralkyl)amines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |